Page 15 - BH-2-1

Brain & Heart Hypochloremia in refractory heart failure

doi: 10.1001/archinte.1988.00380020030006 doi: 10.1016/j.cardfail.2018.09.014
33. Gottlieb SS, Khatta M, Wentworth D, Roffman D, Fisher ML, 44. Ferreira JP, Girerd N, Duarte K, et al. Serum chloride
Kramer WG. The effects of diuresis on the pharmacokinetics and sodium interplay in patients with acute myocardial
of the loop diuretics furosemide and torsemide in patients infarction and heart failure with reduced ejection fraction:
with heart failure. Am J Med. 1998;104(6):533-538. An analysis from the high-risk myocardial infarction
doi: 10.1016/S0002-9343(98)00111-9 database initiative. Circ Heart Fail. 2017;10(2):e003500.
34. Loon NR, Wilcox CS, Unwin RJ. Mechanism of impaired doi: 10.1161/CIRCHEARTFAILURE.116.003500
natriuretic response to furosemide during prolonged 45. Grodin JL. Pharmacologic approaches to electrolyte
therapy. Kidney Int. 1989;36(4):682-689. abnormalities in heart failure. Curr Heart Fail
doi: 10.1038/ki.1989.246 Rep. 2016;13(4):181-189.
35. Wilcox CS, Testani JM, Pitt B. Pathophysiology of diuretic doi: 10.1007/s11897-016-0295-7
resistance and its implications for the management of 46. Kataoka H. Rationale of the “chloride theory” as an
chronic heart failure. Hypertension. 2020;76(4):1045-1054. explanation for neurohormonal activity in heart failure
doi: 10.1161/HYPERTENSIONAHA.120.15205 pathophysiology: Literature review. J Clin Exp Cardiol.
2019;10:634.
36. Ter Maaten JM, Damman K, Hanberg JS, et al.
Hypochloremia, diuretic resistance, and outcome in patients 47. Justin LG, Jeffrey MT, Ambarish P, et al. Perturbations in
with acute heart failure. Circ Heart Fail. 2016;9(8):e003109. serum chloride homeostasis in heart failure with preserved
ejection fraction: Insights from TOPCAT. Eur J Heart Fail.
doi: 10.1161/CIRCHEARTFAILURE.116.003109 2018;20(10):1436-1443.
37. Simon J, Onyebeke C, Cheng SJ, Grodin J, Tang WHW, doi: 10.1002/ejhf.1229
Testani JM. Hypochloremia is strongly and independently
associated with mortality in patients with chronic heart 48. Funder JW. Aldosterone and mineralocorticoid receptors
failure. J Card Fail. 2015;21(8):S89-S90. in the cardiovascular system. Prog Cardiovasc Dis.
2010;52(5):393-400.
doi: 10.1016/j.cardfail.2015.06.267
doi: 10.1016/j.pcad.2009.12.003
38. Pleinis JM, Norrell L, Akella R, et al. WNKs are
potassium-sensitive kinases. Am J Physiol Cell Physiol. 49. Kazory A, Ronco C. Emergence of chloride as an overlooked
2021;320(5):C703-C721. cardiorenal connector in heart failure. Blood Purif.
2020;49(1-2):219-221.
doi: 10.1152/ajpcell.00456.2020
doi: 10.1159/000503774
39. Alessi DR, Zhang J, Khanna A, Hochdörfer T, Shang Y,
Kahle KT. The WNK-SPAK/OSR1 pathway: Master 50. Fudim M, Hernandez AF, Felker GM. Role of volume
regulator of cation-chloride cotransporters. Sci Signal. redistribution in the congestion of heart failure. J Am Heart
2014;7(334):re3. Assoc. 2017;6(8):e006817.
doi: 10.1126/scisignal.2005365 doi: 10.1161/JAHA.117.006817
40. Testani JM, Brisco MA, Turner JM, et al. Loop diuretic 51. Champagne K, Grgurich P, Nault K. Identifying drivers
efficiency: A metric of diuretic responsiveness with of hyperchloremia in critically ill adults. Crit Care Med.
prognostic importance in acute decompensated heart 2022;50(1):490.
failure. Circ Heart Fail. 2014;7:261-270. doi: 10.1097/01.ccm.0000810272.97123.a7
doi: 10.1161/CIRCHEARTFAILURE.113.000895 52. Hanberg JS, Rao V, Ter Maaten JM, et al. Hypochloremia
41. Testani JM, Chen J, McCauley BD, Kimmel SE, Shannon RP. and diuretic resistance in heart failure: Mechanistic insights.
Potential effects of aggressive decongestion during the Circ Heart Fail. 2016;9(8):e003180.
treatment of decompensated heart failure on renal function doi: 10.1161/CIRCHEARTFAILURE.116.003180
and survival. Circulation. 2010;122:265-272.
53. Kataoka H. The “chloride theory”, a unifying hypothesis for
doi: 10.1161/CIRCULATIONAHA.109.933275 renal handling and body fluid distribution in heart failure
42. Suri SS, Pamboukian SV. Optimal diuretic strategies in heart pathophysiology. Med Hypotheses. 2017;104:170-173.
failure. Ann Transl Med. 2021;9(6):517. doi: 10.1016/j.mehy.2017.06.005
doi: 10.21037/atm-20-4600 54. Steuber TD, Janzen KM, Howard ML. A systematic
43. Kataoka H. Biochemical determinants of changes in plasma review and meta-analysis of metolazone compared to
volume after decongestion therapy for worsening heart chlorothiazide for treatment of acute decompensated heart
failure. J Card Fail. 2019;25(3):213-217. failure. Pharmacotherapy. 2020;40(9):924-935.

Volume 2 Issue 1 (2024) 9 https://doi.org/10.36922/bh.2257